2010 IPO

InVivo Therapeutics Stock

InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.

Sign up today and learn more about InVivo Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About InVivo Therapeutics Stock

InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of research initiated in the laboratories of Robert Langer, PhD, of the Massachusetts Institute of Technology, Jay Vacanti, MD, of the Massachusetts General and Children’s Hospitals in Boston, and Yang Teng, PhD, MD, of Harvard's Brigham and Women's Hospital.

Funding History

December 2010$13.0M
October 2011$30.0M
March 2016$32.2M
January 2018$15.2M



Sean Moran


Kenneth DiPietro

Chief Scientific Officer

Thomas R. Ulich

Director/Non-Executive Chairman of the Board

John A. McCarthy, Jr.

President,CEO & CMO

Richard Toselli

Chief Medical Officer

Lou Vaickus

Interim CFO

Steven F. McAllister

Chief Technology Officer

Brian Hess

Vice President, Business Development

Christopher McNulty

Chief Science Officer

Christopher Pritchard

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: